T2 Biosystems, Inc. 4
4 · T2 Biosystems, Inc. · Filed May 2, 2017
Insider Transaction Report
Form 4
DEPTULA-HICKS DARLENE M
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-05-01+175,000→ 175,000 totalExercise: $4.74Exp: 2027-05-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the total shares vest on 05/01/2018, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/01/2021.